This invention discloses compounds that alter PPAR activity. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing hyperlipidemia and hypercholesteremia in a mammal. The present invention also discloses method for making the disclosed compounds.

 
Web www.patentalert.com

< 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity

< Pyrazole derivatives as cannabinoid receptor antagonists

> Tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them

> PPAR-activating compound and pharmaceutical composition comprising the compound
~ 00287